TECHNOLOGY FOCUS - INORGANIC CHEMISTRY - Preferred Components: The current collector comprises a metal or metalloid or conductive carbon. The current collector comprises aluminum, copper, gold, nickel, or titanium. The electrolyte comprises an anion-cation pair, where the cation comprises an alkali metal, an alkaline earth metal, a lanthanide, a tetraalkyl ammonium cation, aluminum or zinc and the anion comprises hydroxide ion (OH-), hexafluoro phosphate ion (PF6-), perchlorate ion (ClO4-), tetrafluoroborate ion (BF4-), triflate ion (CF3SO3-), or antimony hexafluoride ion (SbF6-).    TECHNOLOGY FOCUS - INSTRUMENTATION AND TESTING - Preferred Components: (I) comprises: activated carbon and the alliform carbon particles; and carbon black and the alliform carbon particles. The garment apparatus further comprises metallic threads or fibrils. The alliform carbon layer is part of a wireless antenna system or a wearable computer system. The alliform carbon layer provides for the capture, storage, and later release of energy associated with the movement of the wearer. The energy associated with the movement of the wearer is transformed to electrical energy by a piezoelectric device. The garment apparatus is applied to a piece of footwear. The medical apparatus further comprises: a conductive fluid comprising an electrolyte; silver or zinc; and a drug reservoir incorporated into an iontophoretic, electrophoretic, electroosmotic or electroporative device, where the drug reservoir has a barrier membrane contacting the tissue surface of a patient, where the conductive fluid is an aqueous hydrogel. The first and second electrode each comprises a three dimensionally porous matrix of alliform carbon particles, where the alliform carbon particles have a mean diameter as measured by transmission electron micrograph photomicrograph image analysis of 2-30 nm, the alliform carbon particles being substantially physically connected. The thickness of each solid body of three dimensionally porous matrix of alliform carbon particles is 1-20 microns. The electrolyte is contained within aqueous based solution or a polar organic solvent, where the solvent comprises acetonitrile, gamma -butyl lactone, dimethylformamide, 1,2-dimethoxyethane, dimethyl carbonate, diethyl carbonate, dipropyl carbonate, ethylene carbonate, nitromethane, propylene carbonate, or sulfalone. The electrolyte comprises salts of sulfuric acid, perchloric acid, hexafluorophosphoric acid, tetrafluoroboric acid and a tetraalkyl and/or amine salt of perfluoroalkylsulfonic acid. The pair of electrodes are superposed on a substrate and arranged in a planar array, with the electrolyte interposed between and physically separating the electrodes, where the planar array is characterized as occupying a lateral planar area and having a vertical depth. The current collector of at least one electrode is positioned above or underneath the corresponding solid body of three-dimensionally porous matrix of alliform carbon particles. The pair of electrodes are arranged in an interdigital arrangement, where each electrode comprises interdigital electrode fingers, where the fingers are characterized as having a length, width, and vertical distance, and the interdigital arrangement characterized as having an interdigital spacing between the fingers. The widths of the electrode fingers of each electrode are 20-10 mm or 100 nm to 1000 microns, preferably 100-500 microns. The energy storage device: exhibits capacitance when a voltage polarity is applied across the pair of electrodes; maintains more than 95% of its original capacitance when the polarity of the electrodes is cycled more than 10000 times; exhibits a near-linear relationship between discharge current and scan rate up to a scan rate of at least 175 Vs-1, preferably 100 Vs-1.    TECHNOLOGY FOCUS - ORGANIC CHEMISTRY - Preferred Components: The alliform carbon particles have: a mean diameter of 1-20 nm, preferably 2-5 nm; a mean specific surface area of 250-750 (preferably 500) m2g-1; and a substantially unimodal size distribution. The alliform carbon particles are present at 2-50 wt.%. preferably 20-25 wt.%. The thickness of the layer comprising alliform carbon is 20-500 nm, preferably 20-100 nm. The layer of alliform carbon is transparent to: electromagnetic radiation; infrared, visible or UV light; or visible light. The layer of alliform carbon is organized into a pattern. Preferred Method: The hot pressing or annealing is conducted at 1200-2500 C, preferably 1500-2000 C. The detonated diamond or preformed alliform carbon additionally contains an organic binder, and the hot pressing or annealing results in the conversion of this organic binder to amorphous or graphitic carbon. The two layers of alliform carbon are applied using a printing technique. The alliform carbon particles are derived from detonation nanodiamond powders. The alliform carbon particles are prepared by a process comprising annealing detonation nanodiamond powders. The method-1 further comprises annealing the detonation powder at 1200-2000 C, preferably 1800 C. The alliform carbon particles are organized in a pattern on a substrate. In the method-1, a patterned current collector is formed on the substrate before the alliform carbon particles are organized on the patterned current collector. The alliform carbon particles are organized in a pattern on patterned current collector using an electrochemical deposition technique. The alliform carbon particles are organized in a pattern on a substrate surface by use of lithographic techniques, physical or chemical deposition, or electrochemical deposition techniques. The alliform carbon particles are organized by use of lithographic or electrochemical deposition techniques. The alliform carbon particles are organized on a current collector so as to be in electrical communication in it. The method-1 further comprises depositing the current collector on at least one solid body of alliform carbon particles so as to be in electrical communication in it.    TECHNOLOGY FOCUS - PHARMACEUTICALS - Preferred Components: The drug reservoir contains thymol, cetylpyridinium chloride, benzalkonium chloride, chlorhexidine, stannous fluoride, octenidine, decapinal, triclosan, nystatin, chlortrimazole, fluconazole, miconazole, ketoconazole, itraconazole, amphotericin B, acyclovir, idoxuridine, ibuprofen, flurbiprofen, ketoprofen, naproxen, aspirin, piroxicam, hydrocortisone, betamethasone, dexamethasone, beclomethasone dipropionate, fluocinonide, pilocarpine, retin A, lidocaine hydrochloride, hydrocortisone, fluoride, penicillin, dexamethasone sodium phosphate, insulin, antibiotics, retinoids, antimicrobials, and keratolytic agents such as tretinoin, isotretinoin, motretinide, adapalene, tazarotene, azelaic acid, retinol, salicylic acid, benzoyl peroxide, resorcinol, sulfur, sulfacetamide, tetracycline, clindamycin, metronidazole, erythromycin, soy isoflavones, retinol, kojic acid, kojic dipalmitate, hydroquinone, arbutin, transexamic acid, niacin, vitamin C, azelaic acid, linolenic acid, linoleic acid, and their salts. The drug reservoir contains antiinfectives, antibiotics, antiviral agents, analgesics, fentanyl, sufentanil, buprenorphine, analgesic combinations, anesthetics, anorexics, antiarthritics, antiasthmatic agents, terbutaline, anticonvulsants, antidepressants, antidiabetic agents, antidiarrheals, antihistamines, antiinflammatory agents, antimigraine preparations, antimotion sickness, scopolamine, ondansetron, antinauseants, antineoplastics, antiparkinsonism drugs, cardiostimulants, dobutamine, antipruritics, antipsychotics, antipyretics, antispasmodics, gastrointestinal and urinary, anticholinergics, sympathomimetics, xanthine derivatives, cardiovascular preparations, calcium channel blockers, nifedipine, beta-blockers, beta-agonists, salbutamol, ritodrine, antiarrythmics, antihypertensives, atenolol, angiotensin-converting-enzyme inhibitors, diuretics, vasodilators, coronary, peripheral and cerebral, central nervous system stimulants, cough and cold preparations, decongestants, diagnostics, hormones, parathyroid hormone, growth hormone, insulin, hypnotics, immunosuppressives, muscle relaxants, nicotine, parasympatholytics, parasympathomimetics, anti-oxidants, nicotine, prostaglandins, psychostimulants, sedatives, tranquilizers, skin acting anti-oxidants, caretenoids, ascorbic acid (vitamin C), vitamin E, antiwrinkling agents, retinoids, retinol (vitamin A alcohol), alpha-hydroxic acids, beta-hydroxy acid, salicylic acid, combination-hydroxy acids and poly-hydroxy acids, and hydrolyzed and soluble collagen, moisturizers, hyaluronic acid, anticellulite agents, aminophyllines, skin bleaching agents, retinoic acid, hydroquinone, peroxides, botanical preparations, extracts of Aloe vera, wild yam, hamamelitanin, ginseng, witch hazel, water and green tea. The drug reservoir contains miconazole, econazole, ketoconazole, sertaconazole, itraconazole, fluconazole, voriconazole, clioquinol, bifoconazole, terconazole, butoconazole, tioconazole, oxiconazole, sulconazole, saperconazole, clotrimazole, undecylenic acid, haloprogin, butenafine, tolnaftate, nystatin, ciclopirox olamine, terbinafine, amorolfine, naftifine, elubiol, griseofulvin, mupirocin, neomycin sulfate bacitracin, polymyxin B, 1-ofloxacin, chlortetracycline, oxytetracycline, tetrachcycline, clindamycin, gentamicin, metronidazole, hexylresorcinol, methylbenzethonium, phenol, tea tree oil, lodopropynyl butylcarbamate, diazolidinyl urea, chlorhexidene digluconate, chlorhexidene acetate, chlorhexidene isethionate, chlorhexidene, benzalkonium, benzethonium, triclocarbon, polyhexamethylene biguanide, cetylpyridium chloride, methyl benzothonium, 2,4,4f,-trichloro-2-hydroxy diphenyl ether, parachlorometa xylenol, or their salts.    TECHNOLOGY FOCUS - POLYMERS - Preferred Components: The paint or glue further comprises a polymer comprising a benzoxazine, bismaleimide, epoxy, fluorinated or perfluorinated polymer, melamine resin, polyalkylene, polyamide, polyamide-imide, polyaryletherketone, polyether etherketone, polyester, polyethylenenimine, polyethersulfone, poly (p-phenylene sulfide), polyimide, polyurethane, polyvinyl chloride and/or vinyl ester. The electrically conductive or semi-conductive polymer comprises poly(fluorene), polypyrene, polyazulene, polynaphthalene, poly(pyrrole), polycarbazole, polyindole, polyazepine, polyaniline, polyquinoline, poly(thiophene), poly(p-phenylene sulfide), poly(acetylene), poly(polyphenylene vinylene), and/or their copolymer. The ionomer comprises methacrylic or acrylic acid, urethane, butadiene-styrene-acrylic acid terpolymer ionomers, perfluorinated polymers, sulfonated polyphenylene oxide, phosphonated polyphenylene oxide, polysulfone, polyethersulfone, polybenzimidazole, polyimide, polystyrene, polyethylene, polytrifluorostyrene; polyetheretherketone; liquid crystal polymer and/or their copolymer. The fabric provides partial or complete electromagnetic shielding to the surfaces covered by the garment. The substrate comprises glass, quartz, or flexible or rigid plastics. The substrate is transparent to visible light. The substrate is a textile fabricated from natural or synthetic fibers, a sheet of polymeric material and/or paper. The layer comprising alliform carbon is capable of acting as a conductor, an electrode, or an energy storage device. The mean pore size of the matrix is 1-50 nm, preferably 1-10 nm. The matrix is substantially free of organic binder. ACTIVITY - Vulnerary; Dermatological; Antiseborrheic; Antibacterial; Antiinflammatory; Antipsoriatic; Virucide; Muscular-Gen.; Metabolic; Analgesic; Vasotropic.    MECHANISM OF ACTION - None given.